Sign in to fuzzto save your conversations, follow your research and come back anytime.
Navin Fluorine International
SectorChemicals
Navin Fluorine International Limited is an Indian company specializing in fluorine chemistry. It manufactures refrigeration gases, inorganic fluorides, and specialty organofluorines. The company operates manufacturing units in Surat, Gujarat and Dewas, Madhya Pradesh, with an additional site in Dahej, Gujarat. Navin Fluorine provides contract research and manufacturing services, focusing on the production of fluorine-based chemicals for various industries including pharmaceuticals, agrochemicals, and petrochemicals. The company has developed over 40 commercial products and serves several Fortune 500 companies. In recent years, Navin Fluorine has expanded its operations, including the establishment of a High Performance Products business at Dahej and investments in new manufacturing capabilities.
In the news
Jefferies raises Navin Fluorine target to ₹9,405, forecasts 14% upside
Navin Fluorine maintains Rs 8812 target amid strong Q1 performance
Kush Bohra Recommends Aditya Birla Capital, IKS & Navin Fluorine
MarketSmith India Recommends Navin Fluorine, Allied Blenders
Experts Advise Sell CEAT, IEX; Hold NCC; Buy NTPC Green
Navin Fluorine International allots 5,200 equity shares under ESOS
Bajaj Finance, Waaree Engineering & Navin Fluorine: Top Stock Picks
Navin Fluorine hits 52-week high on strong Q4 earnings
Navin Fluorine declares 430% final dividend after Q4 profit doubles
Navin Fluorine shares rise 10% on capacity expansion plans
Prabhudas Lilladher sets Navin Fluorine target at ₹7038
Navin Fluorine shares hit record high as Q3 PAT drops 14%
The Quarter story
The two most recent quarterly results, compared side-by-side.
Navin Fluorine delivers strong top-line and margin expansion in Q1 FY27, driven by robust export demand and disciplined cost control.
Consolidated net revenue grew from ₹542.95 Cr in Q1 FY26 to ₹694.68 Cr in Q1 FY27, confirming steady top-line expansion.
Interest expenses rose from ₹0.84 Cr in Q1 FY26 to ₹4.88 Cr in Q1 FY27, increasing debt servicing costs.
Operating EBITDA margin surged from 28.2% in Q3 FY26 to 35.3% in Q1 FY27, reflecting strong pricing power.
Raw material costs grew from ₹239.44 Cr in Q1 FY26 to ₹292.40 Cr in Q1 FY27, reflecting input inflation pressure.
High Performance Products revenue rose from ₹407 Cr in Q1 FY26 to ₹540 Cr in Q1 FY27, driving segment growth.
Employee expenses increased from ₹52.61 Cr in Q2 FY26 to ₹62.43 Cr in Q1 FY27, signaling rising headcount costs.
CDMO international revenue mix recovered from 94% in Q3 FY26 to 98% in Q1 FY27, sustaining export demand.
Specialty chemicals revenue dropped from ₹360 Cr in Q4 FY26 to ₹325 Cr in Q1 FY27, indicating order normalization.
Profit after tax climbed from ₹112.76 Cr in Q1 FY26 to ₹190.64 Cr in Q1 FY27, delivering consistent bottom-line gains.
CDMO domestic revenue mix fell from 3% in Q1 FY26 to 2% in Q1 FY27, showing limited local demand growth.